These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 34256643)
1. Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series. Wunderlich-Sperl F; Kautzky S; Pickem C; Hörmann C Int J Artif Organs; 2021 Oct; 44(10):694-702. PubMed ID: 34256643 [TBL] [Abstract][Full Text] [Related]
2. Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: A retrospective study. Akil A; Ziegeler S; Rehers S; Ernst EC; Fischer S Int J Artif Organs; 2022 Jul; 45(7):615-622. PubMed ID: 35695200 [TBL] [Abstract][Full Text] [Related]
3. Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry. Hayanga JWA; Song T; Durham L; Garrison L; Smith D; Molnar Z; Scheier J; Deliargyris EN; Moazami N Crit Care; 2023 Jun; 27(1):243. PubMed ID: 37337243 [TBL] [Abstract][Full Text] [Related]
4. Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series. Kogelmann K; Scheller M; Drüner M; Jarczak D J Intensive Care Soc; 2020 May; 21(2):183-190. PubMed ID: 32489416 [TBL] [Abstract][Full Text] [Related]
6. CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm. Acevedo AC; Zoller M; Scharf C; Liebchen U; Irlbeck M; Schroeder I Case Rep Crit Care; 2021; 2021():9937499. PubMed ID: 34650819 [TBL] [Abstract][Full Text] [Related]
7. Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia. Ruiz-Rodríguez JC; Chiscano-Camón L; Ruiz-Sanmartin A; Palmada C; Paola Plata-Menchaca E; Franco-Jarava C; Pérez-Carrasco M; Hernández-González M; Ferrer R Front Med (Lausanne); 2021; 8():779038. PubMed ID: 35083241 [No Abstract] [Full Text] [Related]
8. Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients. Nassiri AA; Hakemi MS; Miri MM; Shahrami R; Koomleh AA; Sabaghian T Artif Organs; 2021 Nov; 45(11):1338-1347. PubMed ID: 34152629 [TBL] [Abstract][Full Text] [Related]
9. Hemoadsorption in acute respiratory distress syndrome patients requiring venovenous extracorporeal membrane oxygenation: a systematic review. Li W; Chen Y; Li D; Meng X; Liu Z; Liu Y; Fan H Respir Res; 2024 Jan; 25(1):27. PubMed ID: 38217010 [TBL] [Abstract][Full Text] [Related]
11. Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation. Lewis TC; Merchan C; Toy B; Goldenberg RM; Geraci TC; Chang SH; Galloway AC; Smith DE; Moazami N ASAIO J; 2021 Aug; 67(8):856-861. PubMed ID: 34339400 [TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
13. The potential role of extracorporeal cytokine removal with CytoSorb® as an adjuvant therapy in Acute Respiratory Distress Syndrome. Tomescu D; Popescu M; Akil A; Nassiri AA; Wunderlich-Sperl F; Kogelmann K; Molnar Z; Alharthy A; Karakitsos D Int J Artif Organs; 2023 Dec; 46(12):605-617. PubMed ID: 38037333 [TBL] [Abstract][Full Text] [Related]
14. Cytokine Adsorption Therapy during Extracorporeal Membrane Oxygenation in Adult Patients with COVID-19. Rodeia SC; Martins FL; Fortuna P; Bento L Blood Purif; 2022; 51(9):791-798. PubMed ID: 34856539 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal Cytokine Removal in Critically Ill COVID-19 Patients: A Case Series. Virág M; Rottler M; Ocskay K; Leiner T; Horváth B; Blanco DA; Vasquez A; Bucsi L; Sárkány Á; Molnár Z Front Med (Lausanne); 2021; 8():760435. PubMed ID: 34869464 [No Abstract] [Full Text] [Related]
16. Hemoadsorption in cardiac shock with bi ventricular failure and giant-cell myocarditis: A case report. Dogan G; Hanke J; Puntigam J; Haverich A; Schmitto JD Int J Artif Organs; 2018 Aug; 41(8):474-479. PubMed ID: 29843541 [TBL] [Abstract][Full Text] [Related]
17. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Bruenger F; Kizner L; Weile J; Morshuis M; Gummert JF Int J Artif Organs; 2015 Feb; 38(2):113-6. PubMed ID: 25656010 [TBL] [Abstract][Full Text] [Related]
18. Continuous renal replacement therapy and extracorporeal membrane oxygenation: implications in the COVID-19 era. Roberts SH; Goodwin ML; Bobba CM; Al-Qudsi O; Satyapriya SV; Tripathi RS; Papadimos TJ; Whitson BA Perfusion; 2023 Jan; 38(1):18-27. PubMed ID: 34494489 [TBL] [Abstract][Full Text] [Related]
19. Application of extracorporeal therapies in critically ill COVID-19 patients. Zhou Z; Kuang H; Ma Y; Zhang L J Zhejiang Univ Sci B; 2021 Sept 15; 22(9):701-717. PubMed ID: 34514751 [TBL] [Abstract][Full Text] [Related]
20. Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome. Geraci TC; Kon ZN; Moazami N; Chang SH; Carillo J; Chen S; Fargnoli A; Alimi M; Pass H; Galloway A; Smith DE J Card Surg; 2021 Nov; 36(11):4256-4264. PubMed ID: 34219277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]